![Chemical structure of 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one, CAS 147-94-4](https://api.angenesci.com/structure/488/147-94-4.png)
No data
No data
No data
| CAS Number | 147-94-4 |
| Catalog Number | AG0034OE(AGN-PC-0Q12BX) |
| Chemical Name | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
| EC Number | 205-705-9 |
| IUPAC Name | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
| InChI | InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 |
| InChI Key | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
| MDL Number | MFCD00066487 |
| Molecular Formula | C9H13N3O5 |
| Molecular Weight | 243.2166 |
| SMILES | O=C1N=C(N)C=CN1[C@H]2[C@H]([C@@H]([C@@H](CO)O2)O)O |
| UNII | 04079A1RDZ |
| Synonyms | Ara C,
Ara-C,
Arabinofuranosylcytosine,
Arabinoside, Cytosine,
Arabinosylcytosine,
Aracytidine,
Aracytine,
beta Ara C,
beta-Ara C,
Cytarabine,
Cytarabine Hydrochloride,
Cytonal,
Cytosar,
Cytosar U,
Cytosar-U,
Cytosine Arabinoside,
cytarabine,
147-94-4,
Cytosine arabinoside,
Ara-C,
Arabinocytidine,
Cytosar,
Arabinosylcytosine,
Cytarabin,
Tarabine,
Alexan,
Udicil,
Cytosar-U,
1-beta-D-Arabinofuranosylcytosine,
Arabitin,
Aracytin,
Cytarabina,
Arafcyt,
Depocyt,
Erpalfa,
DepoCyte,
Arabinofuranosylcytosine,
Citarabina,
Cytarabinum,
Aracytine,
Aracytidine,
Cytosinearabinoside,
Cytarabinoside,
Cytosine beta-D-arabinofuranoside,
Cytosine-beta-D-arabinofuranoside,
Cytonal,
beta-D-Arabinosylcytosine,
Cytosine arabinofuranoside,
Depocyt (liposomal),
Cytarabinum [INN-Latin],
Citarabina [INN-Spanish],
AraC,
Cytosine beta-D-arabinoside,
Spongocytidine,
beta-Ara C,
Iretin,
Cytosine-1-beta-D-arabinofuranoside,
4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one,
1beta-D-Arabinosylcytosine,
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone,
Cytosine arabinose,
1beta-Arabinofuranasylcytosine,
Cytosine 1-beta-D-arabinofuranoside,
1beta-D-Arabinofuranosylcytosine,
1-beta-D-Arabinofaranosylcytosine,
Cytosine arabinoside (VAN),
beta-Arabinosylcytosine,
Beta-cytosine arabinoside,
Cytosine-beta-arabinoside,
CHX 3311,
1-Arabinofuranosylcytosine,
1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone,
cytarabine liposome injection,
4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one,
Cytosine, beta-D-arabinoside,
CCRIS 913,
1-beta-D-Arabinosylcytosine,
UNII-04079A1RDZ,
Arabinoside C,
Cytosine, 1-beta-D-arabinosyl-,
HSDB 3049,
(beta-D-Arabinofuranosyl)cytosine,
EINECS 205-705-9,
MFCD00066487,
Cytosine, 1-beta-D-arabinofuranosyl-,
CHEMBL803,
NSC 287459,
U 19920A,
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin,
AI3-52329,
2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-,
AR3,
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech],
C9H13N3O5,
CHEBI:28680,
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech],
UHDGCWIWMRVCDJ-CCXZUQQUSA-N,
04079A1RDZ,
1-beta-D-arabinofuranosyl-cytosine,
U-19920,
Cytarabine, 98%,
4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone,
1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside,
arabinocytosine,
NCGC00093356-03,
2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS],
NCI-C04728,
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine,
DSSTox_CID_2877,
AC-1075,
U-19,920,
1-(arabinofuranosyl)cytosine,
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,
DSSTox_RID_76771,
DSSTox_GSID_22877,
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one,
2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-,
Cytarbel,
Ara-Cytidine,
Arabinosyl Cytosine,
CAS-147-94-4,
SMR000449317,
Depocyt (TN),
Cytarabine [USAN:INN:BAN:JAN],
Cytartbine,
1-beta-arabinofuranosylcytosine,
SR-01000075773,
NSC287459,
AK-54744,
1-.beta.-D-arabinofuranosyl-cytosine,
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon,
Cytarabine [USAN:USP:INN:BAN:JAN],
MK 8242,
Cytarabine(Cytosar-U),
PubChem14152,
beta -arabinosylcytosine,
1-b-D-ribosyl-Cytosine,
beta -cytosine arabinoside,
Intrathecal cytarabine (also known as ara-C),
beta -D-arabinosylcytosine,
Cytosine-beta -arabinoside,
AC1L1M4F,
AC1Q52OJ,
SCHEMBL3140,
1-b-D-Ribofuranosylcytosine,
1beta -D-Arabinosylcytosine,
BIDD:PXR0139,
cytosine-1b-D-Ribofuranoside,
Lopac0_000316,
KSC917S2P,
MLS000758310,
MLS001066340,
MLS001424023,
1-beta-D-Arabinosyl-Cytosine,
1-beta-delta-ribosyl-Cytosine,
BIDD:GT0371,
Cytosine, beta -D-arabinoside,
Intrathecal (injected into the spinal fluid) DepoCyt,
1beta -Arabinofuranasylcytosine,
Cytarabine (JP17/USP/INN),
GTPL4827,
PYR287,
1-beta-D-ribofuranosyl-Cytosine,
cytosine-1b-delta-Ribofuranoside,
DTXSID3022877,
1beta-delta-Ribofuranosylcytosine,
CTK8B7927,
1beta -D-Arabinofuranosylcytosine,
Cytosine, 1-beta -D-arabinosyl-,
1-beta -d-arabinofuranosylcytosine,
1-beta-D-arabinofuranosyl cytosine,
1-beta-delta-Ribofuranosylcytosine,
Cytosine-beta -D-arabinofuranoside,
HMS2051K19,
HMS2090A18,
HMS2230M16,
HMS3713N12,
1-beta -D-Arabinofaranosylcytosine,
cytosine-1beta-delta-Ribofuranoside,
1-beta-delta-ribofuranosyl-Cytosine,
BCP02876,
CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9),
ZINC3795098,
Tox21_111203,
Tox21_301971,
ANW-58969,
BDBM50087289,
CCG-51297,
EBD145460,
GP6403,
LS-860,
s1648,
(non-labelled)Cytarabine-13C-15N2,
AKOS007930145,
AKOS015896896,
AM84428,
CS-2177,
Cytosine, 1-beta -D-arabinofuranosyl-,
DB00987,
KS-5063,
MCULE-3945147956,
NC00070,
RL01868,
KS-0000022L,
NCGC00093356-04,
NCGC00093356-05,
NCGC00093356-06,
NCGC00142483-02,
NCGC00255381-01,
AJ-45634,
CPD000449317,
HY-13605,
SAM001247012,
SRI-10828-19,
SRI-10828-20,
SRI-10828_24,
AB0005212,
AX8008499,
SL-000002,
TL8001048,
TR-008148,
FT-0082880,
FT-0624314,
ST24043183,
SW197450-5,
C02961,
D00168,
J10463,
K-4708,
1-BETA-D-ARABINOFURANOSYLCYTOSINE; ARA-C,
10163-EP2272828A1,
10163-EP2284920A1,
10163-EP2287165A2,
10163-EP2287166A2,
10163-EP2292603A1,
10163-EP2292620A2,
10163-EP2298764A1,
10163-EP2298765A1,
10163-EP2298774A1,
10163-EP2299509A1,
10163-EP2301921A1,
10163-EP2301926A1,
10163-EP2301936A1,
10163-EP2308843A1,
10163-EP2314558A1,
10163-EP2316452A1,
10163-EP2371810A1,
10163-EP2372804A1,
10163-EP2378585A1,
15153-EP2270018A1,
15153-EP2272832A1,
15153-EP2275420A1,
15153-EP2277565A2,
15153-EP2277566A2,
15153-EP2277567A1,
15153-EP2277568A2,
15153-EP2277569A2,
15153-EP2277570A2,
15153-EP2277865A1,
15153-EP2292280A1,
15153-EP2295055A2,
15153-EP2295416A2,
15153-EP2295426A1,
15153-EP2295427A1,
15153-EP2298748A2,
15153-EP2298764A1,
15153-EP2298765A1,
15153-EP2298768A1,
15153-EP2298778A1,
15153-EP2298780A1,
15153-EP2301928A1,
15153-EP2305642A2,
15153-EP2305689A1,
15153-EP2308833A2,
15153-EP2308855A1,
15153-EP2308861A1,
15153-EP2311453A1,
15153-EP2311808A1,
15153-EP2311825A1,
15153-EP2311829A1,
15153-EP2311840A1,
15153-EP2311842A2,
15153-EP2314590A1,
15153-EP2316832A1,
15153-EP2316833A1,
15187-EP2270008A1,
15187-EP2280012A2,
15187-EP2281815A1,
15187-EP2292233A2,
15187-EP2292615A1,
15187-EP2292617A1,
15187-EP2301928A1,
15187-EP2301933A1,
15187-EP2305640A2,
15187-EP2305671A1,
15187-EP2308833A2,
15187-EP2311827A1,
15187-EP2311840A1,
15187-EP2316832A1,
15187-EP2316833A1,
147C944,
4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone,
C-55053,
SR-01000721860,
J-520199,
J-700005,
J-700166,
SR-01000075773-3,
SR-01000075773-5,
SR-01000721860-6,
1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone,
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl,
BRD-K33106058-001-07-7,
BRD-K33106058-003-20-6,
2(1H)-Pyrimidinone, 4-amino-1-|A-D-arabinofuranosyl-,
2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-,
4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone,
Z1522566619,
2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-,
Cytarabine, European Pharmacopoeia (EP) Reference Standard,
1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine,
Cytarabine, United States Pharmacopeia (USP) Reference Standard,
Cytarabine; 2(1H)-Pyrimidinone,4-amino-1-a-Darabinofuranosyl-,
Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC),
1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine,
Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%,
Cytarabine, Pharmaceutical Secondary Standard; Certified Reference Material,
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one,
cytidine,
Cyclocide,
Cytarabine HCl,
Ara-cell,
Cytosine riboside,
Cytosar U,
beta Ara C,
cytarabine liposome,
Ara C,
Cytosar-U (TN),
Arabinoside, Cytosine,
Arabinofuranosyl Cytidine,
(Arabinofuranosyl)cytosine,
1beta-Ribofuranosylcytosine,
D07XSN,
CYTARABINE HYDROCHLORIDE,
1beta-D-Ribofuranosylcytosine,
cc-278,
1-beta-D-Ribofuranosylcytosine,
Cytarabine (JP15/USP/INN),
cytosine-1beta-D-Ribofuranoside,
CID6253,
Cytosine-1-beta-arabinofuranoside,
Cytarabine [USAN:BAN:INN:JAN],
1-(beta-d-arabinofuranosyl)cytosine,
BTB15125,
DRG-0038,
NSC63878,
C9-H13-N3-O5,
ACN-057139,
CS-M-34862,
Cytosine-1-beta-D-arabinofuranoside hydrochloride,
Cytosine beta-D-arabinofuranoside hydrochloride,
C2035,
Cytosine 1-beta-D-arabinofuranosyl-(6CI8CI),
A10265,
D003561,
Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine,
Citosina, 1-.beta.-D-arabinofuranosyl-(6CI, 8CI),
2(1H)-Pirimidinona, 4-amino-1-beta-D-arabinofuranosil-,
2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-,
4-Amino-1-arabinofuranosyl-2-oxo-1 2-dihydropyrimidine,
2(1H)-Pyrimidinone, 4-amino-1-D-arabinofuranosyl-[CAS],
69-74-9,
Cytosine beta-D-arabinofuranoside, 99%, an antimetabolic agent and DNA synthesis inhibitor - 5G 5g,
|
| Complexity | 383 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 243.086g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 4 |
| Isotope Atom Count | 0 |
| Molecular Weight | 243.219g/mol |
| Monoisotopic Mass | 243.086g/mol |
| Rotatable Bond Count | 2 |
| Topological Polar Surface Area | 129A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -2.1 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335-H350-H360 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

